247 related articles for article (PubMed ID: 21767383)
1. Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma.
Tölle A; Suhail S; Jung M; Jung K; Stephan C
BMC Cancer; 2011 Jul; 11():302. PubMed ID: 21767383
[TBL] [Abstract][Full Text] [Related]
2. Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?
Tölle A; Jung M; Lein M; Johannsen M; Miller K; Moch H; Jung K; Kristiansen G
BMC Cancer; 2009 Jul; 9():248. PubMed ID: 19622156
[TBL] [Abstract][Full Text] [Related]
3. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma.
Teratani T; Domoto T; Kuriki K; Kageyama T; Takayama T; Ishikawa A; Ozono S; Nozawa R
Urology; 2007 Feb; 69(2):236-40. PubMed ID: 17320655
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues.
Das R; Hammamieh R; Neill R; Melhem M; Jett M
Clin Cancer Res; 2001 Jun; 7(6):1706-15. PubMed ID: 11410510
[TBL] [Abstract][Full Text] [Related]
5. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.
Ha YS; Lee GT; Modi P; Kwon YS; Ahn H; Kim WJ; Kim IY
J Urol; 2015 Nov; 194(5):1441-8. PubMed ID: 25796113
[TBL] [Abstract][Full Text] [Related]
6. Importance of brain‑type fatty acid binding protein for cell-biological processes in human renal carcinoma cells.
Tölle A; Krause H; Miller K; Jung K; Stephan C
Oncol Rep; 2011 May; 25(5):1307-12. PubMed ID: 21399875
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell lines.
Takaoka N; Takayama T; Teratani T; Sugiyama T; Mugiya S; Ozono S
BMC Mol Biol; 2011 Jul; 12():31. PubMed ID: 21771320
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.
Ohlsson G; Moreira JM; Gromov P; Sauter G; Celis JE
Mol Cell Proteomics; 2005 Apr; 4(4):570-81. PubMed ID: 15734831
[TBL] [Abstract][Full Text] [Related]
9. The expression of C-FABP and PPARγ and their prognostic significance in prostate cancer.
Forootan FS; Forootan SS; Malki MI; Chen D; Li G; Lin K; Rudland PS; Foster CS; Ke Y
Int J Oncol; 2014 Jan; 44(1):265-75. PubMed ID: 24189640
[TBL] [Abstract][Full Text] [Related]
10. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
11. Study of FABP's interactome and detecting new molecular targets in clear cell renal cell carcinoma.
Wu G; Zhang Z; Tang Q; Liu L; Liu W; Li Q; Wang Q
J Cell Physiol; 2020 Apr; 235(4):3776-3789. PubMed ID: 31602654
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H
BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117
[TBL] [Abstract][Full Text] [Related]
13. The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance.
Al Fayi MS; Gou X; Forootan SS; Al-Jameel W; Bao Z; Rudland PR; Cornford PA; Hussain SA; Ke Y
Oncotarget; 2016 Dec; 7(50):82783-82797. PubMed ID: 27779102
[TBL] [Abstract][Full Text] [Related]
14. Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling.
Farrell M; Fairfield H; Karam M; D'Amico A; Murphy CS; Falank C; Pistofidi RS; Cao A; Marinac CR; Dragon JA; McGuinness L; Gartner CG; Iorio RD; Jachimowicz E; DeMambro V; Vary C; Reagan MR
Elife; 2023 Mar; 12():. PubMed ID: 36880649
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of growth factor Wnt-5A in six urinary malignant cell lines.
Zhuang L; Zhang Z; Guo Y
Chin Med J (Engl); 1999 Mar; 112(3):251-5. PubMed ID: 11593561
[TBL] [Abstract][Full Text] [Related]
16. Role of fatty acid binding proteins (FABPs) in cancer development and progression.
McKillop IH; Girardi CA; Thompson KJ
Cell Signal; 2019 Oct; 62():109336. PubMed ID: 31170472
[TBL] [Abstract][Full Text] [Related]
17. [Expression of fatty acid binding protein in human breast cancer tissues].
Li H; Lu Q; Dong LH; Xue H; Zhou HY; Yang HJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):312-6. PubMed ID: 17428383
[TBL] [Abstract][Full Text] [Related]
18. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer.
Jing C; Beesley C; Foster CS; Rudland PS; Fujii H; Ono T; Chen H; Smith PH; Ke Y
Cancer Res; 2000 May; 60(9):2390-8. PubMed ID: 10811115
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma-associated antigens MK-1 and CEA in urological cancers.
Tomita Y; Arakawa F; Hirose Y; Liao S; Khare PD; Kuroki M; Yamamoto T; Ariyoshi A; Kuroki M
Anticancer Res; 2000; 20(2A):793-7. PubMed ID: 10810356
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
